MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

Model Number 1550300-23

Device Problems Difficult to Remove (1528); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524); Difficult to Advance (2920); Material Deformation (2976)

Patient Problem No Consequences Or Impact To Patient (2199)

Event Date 08/13/2020

Event Type  malfunction  

Manufacturer Narrative

The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.

Event Description

It was reported the procedure was to treat a heavily calcified lesion in the right coronary artery (rca).The 3.0x23 mm xience sierra stent delivery system (sds) failed to cross the target lesion due to the calcification.The sds was removed without issues and an unspecified 3.0x20mm balloon was used to further dilate the lesion.A guideliner catheter was advanced and the same sds was attempted to be advanced through the guideliner catheter, however the sds could not advance through the guideliner catheter.Resistance was felt with the guideliner catheter during removal and the stent struts flared.The guideliner and sds were removed together.There was no adverse patient effect or a clinically significant delay in procedure.An unspecified balloon was used to treat the vessel, and a dissection was observed.Per the physician the dissection was caused by the guideliner catheter and the sds did not cause or contribute to the dissection.The dissection was medically treated.No additional information was provided.

Manufacturer Narrative

H6: device code 2017: re-insertion of device.The device was returned for analysis.A visual, dimensional and functional inspection was performed on the returned device.The reported material deformation and difficult to remove was confirmed.The reported difficult to advance/position could not be tested due to the condition of the returned device.The reported failure to advance could not be tested as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to the design, manufacture or labeling of the device.

• Brand Name: XIENCE SIERRA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
• Type of Device: DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
• Manufacturer (Section D): ABBOTT VASCULAR; 26531 ynez rd.; temecula CA 92591 4628
• MDR Report Key: 10496874
• MDR Text Key: 207041073
• Report Number: 2024168-2020-07415
• Device Sequence Number: 1
• Product Code: NIQ
• UDI-Device Identifier: 08717648227271
• UDI-Public: 08717648227271
• Combination Product (y/n): Y
• PMA/PMN Number: P110019
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: company representative,health
• Type of Report: Initial,Followup
• Report Date: 10/13/2020

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 09/04/2020
• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Expiration Date: 02/02/2021
• Device Model Number: 1550300-23
• Device Catalogue Number: 1550300-23
• Device Lot Number: 0012741
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 08/19/2020
• Date Manufacturer Received: 09/23/2020
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Treatment: GUIDELINER CATHETER
• Patient Age: 60 YR